ClinicalTrials.gov
ClinicalTrials.gov Menu

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00231582
Recruitment Status : Completed
First Posted : October 4, 2005
Last Update Posted : February 25, 2011
Sponsor:
Collaborators:
Ministry of Health, France
Amgen
Baxter Healthcare Corporation
Information provided by:
Assistance Publique - Hôpitaux de Paris